Cargando…
Recent advances in the treatment of multiple sclerosis
Multiple sclerosis (MS) is a chronic inflammatory, immune-mediated, demyelinating, neurodegenerative disorder of the central nervous system. Despite the lack of an etiologic factor, it has been consistently demonstrated that the immune system plays a crucial role in the pathogenesis of MS. The tradi...
Autores principales: | Bennett, Jeffrey L, Miravalle, Augusto A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863296/ https://www.ncbi.nlm.nih.gov/pubmed/27186101 http://dx.doi.org/10.2147/JEP.S7822 |
Ejemplares similares
-
Emerging therapies for treatment of multiple sclerosis
por: Corboy, John R, et al.
Publicado: (2010) -
Current and Emerging Therapies for the Treatment of Multiple Sclerosis: Focus on Cladribine
por: Schreiner, Teri L., et al.
Publicado: (2012) -
Remyelination Therapy in Multiple Sclerosis
por: Harlow, Danielle E., et al.
Publicado: (2015) -
Recent advances in understanding multiple sclerosis
por: Stys, Peter K., et al.
Publicado: (2019) -
Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis
por: Kammona, Olga, et al.
Publicado: (2020)